Euthyrox and Disease progression - a phase IV clinical study of FDA data

Summary:

Disease progression is reported as a side effect among people who take Euthyrox (levothyroxine sodium), especially for people who are female, 60+ old, also take Dexamethasone, and have High blood pressure.

The phase IV clinical study analyzes which people have Disease progression when taking Euthyrox. It is created by eHealthMe based on reports of 8,613 people who have side effects when taking Euthyrox from the FDA, and is updated regularly.

What is Euthyrox?

Euthyrox has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 8,740 Euthyrox users. Check the latest studies of Euthyrox.

What is Disease progression?

Disease progression is found to be associated with 1,800 drugs and 2,256 conditions by eHealthMe. Check the latest studies of Disease progression.

On Jul, 30, 2026

8,613 people reported to have side effects when taking Euthyrox.
Among them, 36 people (0.42%) have Disease progression.

Could Euthyrox cause Disease progression?

Among these 36 people:

What is the gender of people who have Disease progression when taking Euthyrox? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Disease progression when taking Euthyrox? *

What are other drugs people take besides Euthyrox? *

Prednisolone: 10 people, 27.78%
Dexamethasone: 10 people, 27.78%
Amlodipine: 9 people, 25.00%
Cisplatin: 8 people, 22.22%
Pantoprazole Sodium: 8 people, 22.22%
Cyclophosphamide: 8 people, 22.22%
Tamsulosin Hydrochloride: 7 people, 19.44%
Acetaminophen: 6 people, 16.67%
Cytarabine: 6 people, 16.67%
Etoposide: 6 people, 16.67%

What are other side effects people have besides Disease progression? *

Blood Lactate Dehydrogenase Increased: 9 people, 25.00%
Large Intestine Perforation (hole in large intestine): 6 people, 16.67%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 6 people, 16.67%
Thrombocytopenia (decrease of platelets in blood): 5 people, 13.89%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 4 people, 11.11%
Anaemia (lack of blood): 4 people, 11.11%
Weakness: 3 people, 8.33%
Acute Kidney Failure: 3 people, 8.33%
Nausea (feeling of having an urge to vomit): 3 people, 8.33%
Nausea And Vomiting: 3 people, 8.33%

What are the existing conditions these people have? *

High Blood Pressure: 14 people, 38.89%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 8 people, 22.22%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 3 people, 8.33%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 8.33%
Breast Cancer: 3 people, 8.33%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 3 people, 8.33%
Diarrhea: 3 people, 8.33%
Nausea (feeling of having an urge to vomit): 3 people, 8.33%
Abdominal Pain: 3 people, 8.33%
Gastrointestinal Stromal Tumor: 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Euthyrox and have Disease progression?

- Check whether Disease progression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Euthyrox:

Euthyrox (8,740 reports)

Browse all side effects of Euthyrox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Disease progression:

Disease progression (1,800 drugs)

Browse all the conditions that are associated with Disease progression:

Disease progression (2,256 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on levothyroxine sodium (the active ingredients of Euthyrox) and Euthyrox (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.